Calcium-acting drugs modulate expression and development of chronic tolerance to nicotine-induced antinociception in mice. [electronic resource]
Producer: 20060112Description: 959-64 p. digitalISSN:- 0022-3565
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine -- analogs & derivatives
- 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester -- pharmacology
- Analgesics
- Animals
- Calcium -- physiology
- Calcium Channel Agonists -- pharmacology
- Calcium Channel Blockers -- pharmacology
- Calcium Channels, L-Type -- drug effects
- Calcium Signaling -- drug effects
- Calcium-Calmodulin-Dependent Protein Kinase Type 2
- Calcium-Calmodulin-Dependent Protein Kinases -- antagonists & inhibitors
- Drug Tolerance
- Enzyme Activation -- drug effects
- Enzyme Inhibitors -- pharmacology
- Injections, Spinal
- Male
- Mice
- Nicotine -- pharmacology
- Nicotinic Agonists -- pharmacology
- Nimodipine -- pharmacology
- Pain Measurement -- drug effects
- Reaction Time -- drug effects
- Spinal Cord -- drug effects
- Verapamil -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.